|
|
|
|
|
|
Catalyst Pharm Inc (CPRX)
|
|
2.76 +0.14 (+5.34%)
|
10/20/2017 4:00pm
|
|
Open:
|
2.59
|
Pre. Close:
|
2.62
|
|
High:
|
2.76
|
Low:
|
2.56
|
|
Volume:
|
758,118
|
Market Cap:
|
233.37M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.74 - 2.84
|
2.84 - 2.98
|
|
Low:
|
2.28 - 2.37
|
2.37 - 2.52
|
|
Close:
|
2.56 - 2.69
|
2.69 - 2.89
|
|
|
|
|
|
|
Technical analysis (as of: 2017-10-20 4:34:54 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.
|
|
Target:
|
Six months: 3.33 One year: 3.89
|
|
Support:
|
Support1: 2.56 Support2: 2.38
|
|
Resistance:
|
Resistance1:
2.85 Resistance2: 3.33
|
|
Pivot:
|
2.65
|
|
Moving Averages:
|
MA(5): 2.59 MA(20): 2.60
MA(100): 2.67 MA(250): 1.90
|
|
MACD:
|
MACD(12,26):
0.01 Signal(12,26,9):
|
|
%K %D:
|
%K(14,3): 51.52 %D(3): 37.77
|
|
RSI:
|
RSI(14): 60.06
|
|
52-Week:
|
High: 3.20
Low: 0.94 Change(%): 128.1
|
|
Average Vol(K):
|
3-Month: 50504
10-Days 17344
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.CPRX has closed below upper band by 16.9%. Bollinger Bands are 25.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Thu, 11 May 2017 20:26:15 GMT
Catalyst Pharmaceuticals to Present at 16th Annual BIO Investor Forum
Sun, 22 Oct 2017 11:15:00 GMT
Critical Survey: Catalyst Pharmaceuticals (CPRX) versus Its Peers
Fri, 20 Oct 2017 12:22:30 GMT
Are Analysts Turning Critical? – Catalyst Pharmaceuticals, Inc. (CPRX ...
Thu, 12 Oct 2017 12:11:15 GMT
What the Numbers Say About Catalyst Pharmaceuticals, Inc. (CPRX) and Rigel ...
Tue, 10 Oct 2017 10:18:45 GMT
Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
